While some individuals report improvements in symptoms, research is still developing, and peptides should generally be viewed as part of a broader arthritis management strategy
Because AOD 9604 has not completed the full clinical development pathway, its comprehensive side-effect profile in humans is not well characterised and should not be assumed to be benign
F., Chen, N., Simmler, C., Lankin, D
Thus, it was likely that after tail amputation in rats, with/out heparin and warfarin administration, BPC 157 would counteract the consequences of administration of the NOS-blocker, L-NAME (i.e., prothrombotic effect and thereby thrombocytopenia) and/or NOS-substrate, L-arginine (i.e., antithrombotic effect and thereby more bleeding) [2931]
However, the benefits wear off quickly, and injections need repeating every few days for several weeks
When patients learn (sometimes the hard way) that using opioids will not give the high they are looking for and can cause 10/10 withdrawal sickness, its clearly not worth the relapse